Matthew Allaway, DO, detailed benefits of using an emerging transperineal biopsy approach to identify prostate cancer in hard to access areas of a patient’s prostate.
Matthew Allaway, DO
Advertisement
Articles by Matthew Allaway, DO
Matthew Allaway, DO, spoke with CancerNetwork® about a new transperineal biopsy approach to detect cancer in hard-to-reach areas of the prostate.
Advertisement
Latest Updated Articles
Oncology Peer Review On-The-Go: Matthew Allaway, DO, on Transperineal Biopsy Approach for Prostate CancerPublished: January 31st 2022 | Updated:
Matthew Allaway, DO, Discusses Transperineal Biopsy Approach for Prostate CancerPublished: February 26th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Belzutifan Plus Lenvatinib Improves PFS/ORR in Advanced Pretreated RCC
2
Response Rates Show Promise in Phase 1 trial Involving ASCT in Metastatic PDAC
3
What Path to Approval Has Dasatinib Taken in CML/ALL?
4
JSKN003 Receives FDA Fast Track Designation in Advanced PROC
5
